SFI
EDIT icon

Susquehanna Fundamental Investments’s Editas Medicine EDIT Stock Holding History

Susquehanna Fundamental Investments’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-27,642
Closed -$95.9K – 604
2025
Q3 		$95.9K Hold
27,642
– – ﹤0.01% 538
2025
Q2 		$60.8K Sell
27,642
-215,855
-89% -$353K ﹤0.01% 702
2025
Q1 		$282K Sell
243,497
-28,933
-11% -$42.6K ﹤0.01% 957
2024
Q4 		$346K Buy
+272,430
New +$694K ﹤0.01% 917
2024
Q1 		– Sell
-65,463
Closed -$663K – 674
2023
Q4 		$663K Sell
65,463
-53,824
-45% -$472K 0.67% 26
2023
Q3 		$930K Hold
119,287
– – 0.06% 204
2023
Q2 		$982K Sell
119,287
-76,215
-39% -$664K 0.04% 335
2023
Q1 		$1.42M Hold
195,502
– – 0.03% 455
2022
Q4 		$1.73M Buy
+195,502
New +$2.15M 0.03% 519
2021
Q2 		– Sell
-11,642
Closed -$489K – 1684
2021
Q1 		$489K Buy
+11,642
New +$663K 0.01% 1148
2020
Q4 		– Sell
-28,600
Closed -$803K – 1524
2020
Q3 		$803K Hold
28,600
– – 0.02% 722
2020
Q2 		$846K Buy
+28,600
New +$747K 0.04% 494

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna Fundamental Investments's EDIT Position: Q4 2025 in Review

Susquehanna Fundamental Investments sold out of Editas Medicine (EDIT) in Q4 2025, closing a stake of 27,642 shares — an estimated $95.9K sold.

Susquehanna Fundamental Investments first reported a position in EDIT in Q2 2020 and held it in 12 quarters. The position peaked at $1.73M in Q4 2022. 197 funds tracked by Wall St. Rank hold EDIT as of Q4 2025.

  • Susquehanna Fundamental Investments reported no remaining Editas Medicine position as of Q4 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 27,642 Editas Medicine shares in Q4 2025, an estimated $95.9K.
  • Susquehanna Fundamental Investments first reported a position in Editas Medicine in Q2 2020 and held it in 12 quarters.
  • Susquehanna Fundamental Investments's Editas Medicine position peaked at $1.73M in Q4 2022.
  • 197 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2025, filed 17 Feb 2026.